Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.64 |
| ▸ | ECE1 | P42892 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | GHSR | Q92847 | 1/20 | 0.38 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.37 |
| ▸ | GNPAT | O15228 | 1/20 | 0.36 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.36 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.36 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.36 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.35 |
| ▸ | FPGS | Q05932 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8832939 | 1.00 | SLC15A2 (0.64) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL10595108 | 1.00 | SLC15A2 (0.64) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL5598418 | 1.00 | SLC15A2 (0.64) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL259084 | 1.00 | SLC15A2 (0.64) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL2815080 | 0.99 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL29767981 | 0.99 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL4589314 | 0.99 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL29473319 | 0.99 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL4589903 | 0.99 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL2817828 | 0.99 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1012 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747264-A1 | MICELLAR BIOACTIVE COLLAGEN-STIMULATING LIPOPEPTIDE | University of Reading (GB) | 2026-05-27 | — | — | EP | claimed |
| US-20260115258-A1 | PEPTIDE COMPOSITIONS FOR TREATING HAIR LOSS | RESTORE BIOLOGICS HOLDINGS LLC (US) | 2026-04-30 | — | — | US | claimed |
| WO-2026040002-A1 | COMPOSITION AND METHOD FOR CARING FOR THE SKIN | L'OREAL (FR) | 2026-02-26 | — | — | WO | claimed |
| US-20250295762-A1 | COMPOSITE BIOACTIVE COMPOSITIONS AND APPLICATIONS THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2025-09-25 | — | — | US | claimed |
| WO-2025109216-A1 | COSMETIC COMPOSITION COMPRISING A MIXTURE OF PEPTIDES | LABAREAU B.V. (NL) | 2025-05-30 | — | — | WO | claimed |
| CN-115944710-B | Blue copper peptide composition and application thereof | 上海湃肽生物科技有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-119661633-A | Method for full liquid phase synthesis of blue copper peptide | 湖南益安生物科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119638822-A | Full liquid phase synthesis method of oligopeptide-1 | 湖南益安生物科技有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119060121-B | Synthesis method of oligopeptide-1 | 山东美欣生物科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| US-20250073157-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HAIR LOSS | VIAS PARTNERS, LLC | 2025-03-06 | — | — | US | claimed |
| US-4937230-A | ADMINISTERING GLYCYL-HISTIDYL-LYSINE COPPER DERIVATIVE | PROCYTE CORPORATION (US) | 1990-06-26 | — | — | US | claimed |
| WO-1989012441-A1 | COSMETIC AND SKIN TREATMENT COMPOSITIONS | PROCYTE CORPORATION (US) | 1989-12-28 | — | — | WO | claimed |
| EP-0316408-A1 | METHOD OF TUMOR INHIBITION IN WARM-BLOODED ANIMALS | PROCYTE CORPORATION (US) | 1989-05-24 | — | — | EP | claimed |
| EP-0313643-A1 | METHODS AND COMPOSITIONS FOR PREVENTING ULCERS. | PROCYTE CORP (US) | 1989-05-03 | — | — | EP | claimed |
| WO-1988008714-A1 | METHODS AND COMPOSITIONS FOR PREVENTING ULCERS | PROCYTE CORPORATION (US) | 1988-11-17 | — | — | WO | claimed |
| WO-1988008715-A1 | METHOD OF TUMOR INHIBITION IN WARM-BLOODED ANIMALS | PROCYTE CORPORATION (US) | 1988-11-17 | — | — | WO | claimed |
| US-4767753-A | GLYCYL-HISTIDYL-LYSINE DERIVATIVES | PROCYTE CORPORATION (US) | 1988-08-30 | — | — | US | claimed |
| US-4760051-A | Administering to animal a therapeutical amount of glycine -histidine-lysine copper(ii) | PROCYTE CORPORATION, A CORP. OF WA. | 1988-07-26 | — | — | US | claimed |
| US-4732155-A | Implantable chemoattractant system | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1988-03-22 | — | — | US | claimed |
| EP-0189182-A2 | Use of a compound containing GHL-Cu for the manufacture of a medicament for healing wounds | PROCYTE CORPORATION (US) | 1986-07-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250295762-A1 | COMPOSITE BIOACTIVE COMPOSITIONS AND APPLICATIONS THEREOF | BMP2, BMP1, MATR3 | SLC15A2 3505/4885ECE1 3077/4885FOLH1 3277/4885 |
| US-20260115258-A1 | PEPTIDE COMPOSITIONS FOR TREATING HAIR LOSS | PTMS, CHI3L1, CHI3L2 | SLC15A2 3871/4885ECE1 4542/4885FOLH1 415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.